Loading, please wait...
.webp&w=384&q=75){kind=logo}
Verifying...
Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates
Musculoskeletal ultrasound in PsA has revolutionized the way clinicians manage psoriatic disease. Because psoriatic arthritis often presents with diverse clinical signs, early diagnosis remains a significant challenge for many physicians. There are no definitive serological biomarkers available for this condition. Therefore, imaging plays a critical role in identifying early structural and inflammatory changes. Specifically, ultrasound allows doctors to see subclinical synovitis and enthesitis before physical symptoms appear. This early detection is vital for disease interception and prevention.
Notably, ultrasound detects various musculoskeletal involvements across the psoriatic spectrum. It identifies peritendonitis, tenosynovitis, and bursitis with high sensitivity. Moreover, it helps in the differential diagnosis between inflammatory and non-inflammatory joint pain. For instance, clinicians can distinguish between degenerative changes and active psoriatic inflammation. Furthermore, new scoring systems like the DUET score have improved the accuracy of enthesitis assessment. Consequently, these tools support a more precise and timely diagnosis.
Beyond diagnosis, ultrasound serves as a powerful prognostic tool. It predicts future structural damage by identifying active subclinical inflammation. Consequently, this information helps rheumatologists tailor treatment plans to individual patient needs. Additionally, ultrasound is highly effective for monitoring therapeutic response. By observing changes in power Doppler signals, physicians can objectively measure the success of biological therapies. This approach ensures that patients reach their treatment targets faster. Therefore, integrating ultrasound into routine practice promotes a precision medicine approach.
Subclinical psoriatic arthritis describes a phase where psoriasis patients show ultrasound evidence of inflammation, such as enthesitis, without having visible clinical symptoms. Early identification during this stage may prevent progression to established arthritis.
Ultrasound allows clinicians to visualize inflammatory activity that clinical exams might miss. By monitoring power Doppler signals, doctors can determine if a specific drug effectively reduces inflammation or if they need to switch therapies.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult a qualified medical practitioner for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
D'Ignazio E et al. The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring. Curr Rheumatol Rep. 2026 Jun 12. doi: undefined. PMID: 42277548.
Russu E, et al. The role of musculoskeletal ultrasonography in the early diagnosis and differentiation of rheumatoid arthritis, psoriatic arthritis and cutaneous psoriasis. Medical Research Archives. 2025;13(4). doi: 10.18103/mra.v13i4.6488.
RheumNow. New Advances in Ultrasound Diagnostics for Psoriatic Arthritis - ACR Convergence 2025. Published October 25, 2025.
Link will be sent via SMS to your number.
Musculoskeletal ultrasound is essential for managing Psoriatic Arthritis (PsA). It helps doctors detect early subclinical changes, monitor treatment response, and provide personalized care. This review highlights how imaging improves diagnostic accuracy and long-term outcomes in psoriatic disease.
Today
A landmark study published in Cell Genomics reveals that overcrowding, poor sanitation, and socioeconomic inequality are primary drivers of global antimicrobial resistance. Reducing antibiotic consumption alone will not suffice, highlighting the urgent need for structural public health reforms by 2050.
Today
A new study reveals that hyperactivating the Hedgehog pathway with Smoothened Agonist (SAG) causes significant craniofacial development defects in mice. By disrupting cell proliferation and cell-cycle progression during a critical window, SAG exposure leads to cleft lip and other cranial abnormalities.
Today
A study of 221 patients reveals that IVUS guidance during intracoronary brachytherapy for in-stent restenosis significantly reduces target lesion revascularization (21% vs 37%) and major adverse cardiovascular events, ensuring better long-term procedural success and improved patient safety.
Today
Despite their expertise in ergonomics, physiotherapists face high rates of work-related musculoskeletal disorders. New research identifies low back pain and repetitive tasks as leading issues, with female practitioners showing significantly higher risk profiles compared to their male counterparts.
Today
A comprehensive pathological study reveals that medial and intimal calcification follow distinct, inverse distribution patterns in the lower extremities, with medial calcification significantly linked to chronic kidney disease.
Today